World-Class Retina Care. Community-Based Caring.

Shining a Spotlight on Age-related Macular Degeneration (AMD)

Posted On February 20, 2024 / By / Posted in Blog

Shining a Spotlight on Age-related Macular Degeneration (AMD)

February is national age-related macular degeneration (AMD) and low vision awareness month. Low vision is a visual impairment that cannot be corrected by standard eyeglasses, contact lenses, medication, or surgery. AMD, a deterioration, or

read more
Posted On October 31, 2023 / By / Posted in Blog

Three New Clinical Trials Available at Texas Retina

Medical researchers continue to make significant advances in the diagnosis and treatment of retinal conditions, and our physicians remain committed to participating in clinical trials that will improve care for our patients.

read more
Posted On October 18, 2023 / By / Posted in Blog

New Treatments Available for Geographic Atrophy

We know geographic atrophy (GA) can negatively impact patients’ quality of life and independence. While it still cannot be cured, Texas Retina is excited to finally have two new GA treatment options

read more
Posted On August 18, 2023 / By / Posted in Blog

Check Out Our New Patient Education Videos!

We know that anything affecting your sight can be scary, and at Texas Retina, we have always believed in treating our patients as we would our own families. That means not only

read more
Posted On June 7, 2023 / By / Posted in Blog

Texas Retina Associates First in U.S. to Dose a Patient in the Phase 2 SIGLEC Trial

On June 1, 2023, Ashkan Abbey, MD, dosed the first patient in the Phase II SIGLEC Trial, a clinical study evaluating AVD-104, a potential new treatment for geographic atrophy (GA) from age-related

read more
Posted On February 21, 2023 / By / Posted in Blog

FDA Approves First Treatment for Geographic Atrophy

On February 17, 2023, the U.S. Food and Drug Administration (FDA) approved intravitreal pegcetacoplan (brand name Syfovre), the first-ever treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Texas Retina

read more
Posted On November 30, 2021 / By / Posted in Blog

What is Geographic Atrophy?

Approximately 20% of patients with age-related macular degeneration (AMD) will develop a condition called geographic atrophy (GA). It is considered a late stage of AMD and involves chronic, progressive degeneration of regions

read more
Posted On October 19, 2021 / By / Posted in Blog

Dr. Abbey to Speak at Upcoming Retina World Congress Medical Education Event

On October 24, 2021, Texas Retina Associates’ Ashkan M. Abbey, MD, will serve on a distinguished panel of presenters from across the country for a Retina World Congress continuing medical education (CME)

read more